deCODE biostructures Initiates Research Collaboration with Genus Onocology
News Jun 22, 2007
deCODE biostructures, Inc. has announced the signing of a collaborative research agreement with Genus Oncology, LLC.
Under the agreement, deCODE will conduct gene to structure research on protein targets for Genus Oncology. The research and milestone-based collaboration provides Genus Oncology with access to deCODE’s expertise in de novo protein crystal structure determination, from the engineering of synthetic genes to the determination of high resolution crystal structures.
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE